Antibacterial photodynamic therapy: A new treatment for bacterial skin diseases?;Antibakterielle photodynamische therapie: Ein neues verfahren zur behandlung von oberflächlichen bakteriellen infektionen?

Hautarzt

Volumn 56, Issue 11, 2005, Pages 1048-1055

  Maisch, T ^a,b   Szeimies, R M ^b   Lehn, N ^b   Abels, C ^c  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Dr August Wolff GmbH and Co Arzneimittel   (Germany)

Author keywords

Acne vulgaris; MRSA; PDT; Reactive oxygen species; Wound healing

Indexed keywords

ANTIINFECTIVE AGENT; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE;

ANTIBACTERIAL ACTIVITY; BACTERIAL SKIN DISEASE; DERMATOLOGY; DRUG MECHANISM; HUMAN; NONHUMAN; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; REVIEW;

ANTI-BACTERIAL AGENTS; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; SKIN DISEASES, BACTERIAL; TREATMENT OUTCOME;

EID: 27744444958     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-005-0977-7     Document Type: Review

References (59)

1. Angelini G, Vena GA, Meneghini CL (1985) Allergic contact dermatitis to some medicaments. Contact Dermatitis 12:263-269
2. Aveline B (2001) Primary processes in photosensitization mechanisms. Comprehensive Series Photosci 2:17-34
3. Barber MRDM (1948) Infection by penicillin-resistant staphylococci. Lancet 11:641-644
4. Berthiaume F, Reiken SR, Toner M et al. (1994) Antibody-targeted photolysis of bacteria in vivo. Biotechnology (NY) 12:703-706
5. Bertoloni G, Rossi F, Valduga G et al. (1992) Photosensitizing activity of water- and lipid-soluble phthalocyanines on prokaryotic and eukaryotic microbial cells. Microbios 71:33-46
6. Boyle-Vavra S, Labischinski H, Ebert CC et al. (2001) A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother 45:280-287
7. Chambers HF (1997) Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 10:781-791
8. Chapple RM, Inglis B, Stewart PR (1992) Lethal and mutational effects of solar and UV radiation on Staphylococcus aureus. Arch Microbiol 157:242-248
9. Cookson BD (1998) The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 41:11-18
10. Ehrenberg B, Malik Z, Nitzan Y (1985) Fluorescence spectral changes of hematoporphyrin derivative upon binding to lipid vesicles, Staphylococcus aureus and Escherichia coli cells. Photochem Photobiol 41:429-435
11. Fridkin SK (2001) Vancomycin-intermediate and - resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 32:108-115
12. Friedrich CL, Moyles D, Beveridge TJ, Hancock RE (2000) Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother 44:2086-2092
13. Gisby J, Bryant J (2000) Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Antimicrob Agents Chemother 44:255-260
14. Halliwell B, Gutteridge JM (1984) Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1:1396-1397
15. Hamblin MR, O'Donnell DA, Murthy N et al. (2002) Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol 75:51-57
16. Hamblin MR, Zahra T, Contag CH et al. (2003) Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis 187:1717-1725
17. Harder KJ, Nikaido H, Matsuhashi M (1981) Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob Agents Chemother 20:549-552
18. Harkaway KS, McGinley KJ, Foglia AN et al. (1992) Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol 126:586-590
19. Hoger PH (1998) Topical antibiotics and antiseptics. Agents, spectrum, adverse effects. Hautarzt 49:331-347
20. Hoiby N, Jarlov JO, Kemp M et al. (1997) Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 349:167-169
21. Hongcharu W, Taylor CR, Chang Y et al. (2000) Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 115:183-192
22. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A (2001) Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 144:575-579
23. Jekler J (1992) Phototherapy of atopic dermatitis with ultraviolet radiation. Acta Derm Venereol Suppl (Stockh) 171:1-37
24. Jekler J, Bergbrant IM, Faergemann J, Larko O (1992) The in vivo effect of UVB radiation on skin bacteria in patients with atopic dermatitis. Acta Derm Venereol 72:33-36
25. Jevons MP (1961) "Celbenin"-resistant Staphylococci. Br Med J 124-126
26. Jones LR, Grossweiner LI (1994) Singlet oxygen generation by Photofrin in homogeneous and light-scattering media. J Photochem Photobiol B 26:249-256
27. Koning S, van der Wouden JC (2004) Treatment for impetigo. Bmj 329:695-696
28. Koning S, Verhagen AP, van Suijlekom-Smit LW et al. (2004) Interventions for impetigo. Cochrane Database Syst Rev: CD003261
29. Kresken MHD, Studiengruppe (2000) Resistenzentwicklung bei klinisch wichtigen Infektionserregern gegenüber Chemotherapeutika in Mitteleuropa. Chemotherapie J 9:1-36
30. Krutmann J, Ahrens C, Roza L, Arlett CF (1996) The role of DNA damage and repair in ultraviolet B radiation-induced immunomodulation: relevance for human photocarcinogenesis. Photochem Photobiol 63:394-396
31. Maisch T, Feng X, Love B et al. (2003) Photodynamic inactivation of MRSA Staphylococcus aureus. Arch Dermatol Res 294:491 (abstract)
32. McLinn S (1990) A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo. J Am Acad Dermatol 22:883-885
33. Menezes S, Capella MA, Caldas LR (1990) Photodynamic action of methylene blue: repair and mutation in Escherichia coli. J Photochem Photobiol B 5:505-517
34. Minnock A, Vernon DI, Schofield J et al. (1996) Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria. J Photochem Photobiol B 32:159-164
35. Moan J, Berg K (1991) The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 53:549-553
36. Mossman BT (1983) In vitro approaches for determining mechanisms of toxicity and carcinogenicity by asbestos in the gastrointestinal and respiratory tracts. Environ Health Perspect 53:155-161
37. Musher DM, Lamm N, Darouiche RO et al. (1994) The current spectrum of Staphylococcus aureus infection in a tertiary care hospital. Medicine (Baltimore) 73:186-208
38. Nikaido H, Vaara M (1985) Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49:1-32
39. Nitzan Y, Ashkenazi H (2001) Photoinactivation of Acinetobacter baumannii and Escherichia coli B by a cationic hydrophilic porphyrin at various light wavelengths. Curr Microbiol 42:408-414
40. Pfeltz RF, Singh VK, Schmidt JL et al. (2000) Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds. Antimicrob Agents Chemother 44:294-303
41. Pollock B, Turner D, Stringer MR et al. (2004) Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol 151:616-622
42. Raab O (1900) Ueber die Wirkung fluorizierender Stoffe auf Infusorien. Z Biologie 39:524-546
43. Reddi E, Ceccon M, Valduga G et al. (2002) Photophysical properties and antibacterial activity of meso-substituted cationic porphyrins. Photochem Photobiol 75:462-470
44. Rietschel RL (1994) Dermatologic manifestations of antimicrobial adverse reactions with special emphasis on topical exposure. Infect Dis Clin North Am 8:607-615
45. Roland KL, Esther CR, Spitznagel JK (1994) Isolation and characterization of a gene, pmrD, from Salmonella typhimurium that confers resistance to polymyxin when expressed in multiple copies. J Bacteriol 176:3589-3597
46. Rossney AS, Keane CT (2002) Strain variation in the MRSA population over a 10-year period in one Dublin hospital. Eur J Clin Microbiol Infect Dis 21:123-126
47. Schafer M, Schmitz C, Horneck G (1998) High sensitivity of Deinococcus radiodurans to photodynamically-produced singlet oxygen. Int J Radiat Biol 74:249-253
48. Schempp CM, Effinger T, Czech W et al. (1997) Characterization of nonresponders in high dosage UVA1 therapy of acute exacerbated atopic dermatitis. Hautarzt 48:94-99
49. Scherrer R, Gerhardt P (1971) Molecular sieving by the Bacillus megaterium cell wall and protoplast. J Bacteriol 107:718-735
50. Schmitz FJ, Fluit AC, Hafner D et al. (2000) Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 44:3229-3231
51. Sievert D (2002) Staphylococcus aureus resistant to Vancomycin. Morbidity and Mortality Weekly Report, Center Disease Control 51:565-567
52. Szeimies RM, Karrer S, Abels C et al. (1996) 9-Acetoxy-2,7,12,17- tetrakis-(beta-methoxyethyl)-porphycene (ATMPn), a novel photosensitizer for photodynamic therapy: uptake kinetics and intracellular localization. J Photochem Photobiol B 34:67-72
53. Tappeiner HJA (1904) Über die Wirkung der photodynamischen (fluoreszierenden) Stoffe auf Infusorien. Dtsch Arch Klin Med 80:427-487
54. Vaara M, Vaara T (1981) Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium. Antimicrob Agents Chemother 19:578-583
55. Vaara M, Vaara T (1983) Polycations as outer membrane-disorganizing agents. Antimicrob Agents Chemother 24:114-122
56. Vaara M, Vaara T, Jensen M et al. (1981) Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett 129:145-149
57. Valduga G, Breda B, Giacometti GM et al. (1999) Photosensitization of wild and mutant strains of Escherichia coli by meso-tetra (N-methyl-4-pyridyl) porphine. Biochem Biophys Res Commun 256:84-88
58. Van Ginkel CJ, Bruintjes TD, Huizing EH (1995) Allergy due to topical medications in chronic otitis externa and chronic otitis media. Clin Otolaryngol 20:326-328
59. Yoshimura M, Namura S, Akamatsu H, Horio T (1996) Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro. Br J Dermatol 135:528-532